Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Pulmonx's peak revenue was $83.8M in 2024. The peak quarterly revenue was $23.8M in 2024(q4).
Pulmonx's revenue increased from $32.6m in 2019 to $83.8M currently. That's a 157.06% change in annual revenue.
| Fiscal year / year | Pulmonx revenue |
|---|---|
| 2019 | $32.6M |
| 2020 | $32.7M |
| 2021 | $48.4M |
| 2022 | $53.7M |
| 2023 | $68.7M |
| 2024 | $83.8M |
How accurately did Pulmonx's revenue projections match actual performance?
Pulmonx saw the greatest revenue growth in 2021, when revenue increased by 47.91%.
Pulmonx had the lowest revenue growth in 2020, when revenue changed by 0.42%.
| Year | Pulmonx growth |
|---|---|
| 2020 | 0%↑ |
| 2021 | 48%↑ |
| 2022 | 11%↑ |
| 2023 | 28%↑ |
| 2024 | 22%↑ |
Do you work at Pulmonx?
Is Pulmonx transparent about its revenue structure?
| CEO | Glendon E. French |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 202 |
| Date Founded | 1998 |
| Headquarters | Redwood City, California |
| Revenue | $83.8M |
| Net Income | -$58,923,000 |
| Gross Proft | $62.0M (2024) |
| Tax Rate | -0.0% |
| Total Assets | $193,676,000 |
| Ticker | LUNG |
Pulmonx received early financing of $7.1M on 2003-12-10.
| Series | Round size | Date |
|---|---|---|
| Series A | $7M | 12/2003 |
| Series B | $20M | 05/2007 |
| Debt Financing | $7M | 07/2008 |
| Series Unknown | $2.9M | 03/2009 |
| Series C | $32M | 03/2010 |
| Private Equity | $10M | 01/2012 |
| Debt Financing | $20M | 09/2014 |
| Series F | $30M | 01/2017 |
| Series G | $65M | 05/2019 |
| Series H | $66M | 05/2020 |
| Debt Financing | $17M | 05/2020 |
| Investors | Security type |
|---|---|
| MedVenture Associates | Series A |
| Montreux Equity Partners | Series A |
| Latterell Venture Partners | Series B |
| De Novo Ventures LLC | Series B |
| MedVenture Associates | Series B |
| Montreux Equity Partners | Series B |
| Latterell Venture Partners | Series C |
| HealthCap | Series C |
| MedVenture Associates | Series C |
| De Novo Ventures LLC | Series C |
| Kleiner Perkins | Series C |
| POSCO BioVentures Inc | Series C |
| Montreux Equity Partners | Series C |
| Latterell Venture Partners | Private Equity |
| MedVenture Associates | Private Equity |
| De Novo Ventures LLC | Private Equity |
| Kleiner Perkins | Private Equity |
| Montreux Equity Partners | Private Equity |
| Oxford Finance LLC | Debt Financing |
| Boston Scientific Corporation | Series F |
| RTW INVESTMENTS LP | Series G |
| Latterell Venture Partners | Series G |
| Ally Bridge Group | Series G |
| ArrowMark Partners | Series G |
| Boston Scientific Corporation | Series G |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Series G |
| Montreux Equity Partners | Series G |
| Partner Fund Management | Series H |
| Ally Bridge Group | Series H |
| HealthQuest Capital | Series H |
| Adage Capital Management | Series H |
| Rock Springs Capital | Series H |
| CIBC Innovation Banking | Debt Financing |
Zippia gives an in-depth look into the details of Pulmonx, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Pulmonx. The employee data is based on information from people who have self-reported their past or current employments at Pulmonx. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Pulmonx. The data presented on this page does not represent the view of Pulmonx and its employees or that of Zippia.
Pulmonx may also be known as or be related to PULMONX, Pulmonx, Pulmonx Corp, Pulmonx Corp. and Pulmonx Corporation.